Links between the oncoprotein YB-1 and small non-coding RNAs in breast cancer

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Blenkiron, Cherie ^a   Hurley, Daniel G ^a   Fitzgerald, Sandra ^a   Print, Cristin G ^a   Lasham, Annette ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST NEOPLASMS; CELL LINE, TUMOR; FEMALE; HUMANS; MCF-7 CELLS; ONCOGENE PROTEINS; RNA, MESSENGER; RNA, SMALL UNTRANSLATED; Y-BOX-BINDING PROTEIN 1;

EID: 84894224023     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0080171     Document Type: Article

References (87)

1. Eliseeva IA, Kim ER, Guryanov SG, Ovchinnikov LP, Lyabin DN (2011) Y-box-binding protein 1 (YB-1) and its functions. Biochemistry (Mosc) 76: 1402-1433.
2. Lasham A, Print CG, Woolley AG, Dunn SE, Braithwaite AW (2013) YB-1: oncoprotein, prognostic marker and therapeutic target? Biochem J 449: 11-23.
3. Bergmann S, Royer-Pokora B, Fietze E, Jurchott K, Hildebrandt B, et al. (2005) YB-1 provokes breast cancer through the induction of chromosomal instability that emerges from mitotic failure and centrosome amplification. Cancer Res 65: 4078-4087. (Pubitemid 40775644)
4. Habibi G, Leung S, Law JH, Gelmon K, Masoudi H, et al. (2008) Redefining prognostic factors for breast cancer: YB-1 is a stronger predictor of relapse and disease-specific survival than estrogen receptor or HER-2 across all tumor subtypes. Breast Cancer Res 10: R86.
5. Woolley AG, Algie M, Samuel W, Harfoot R, Wiles A, et al. (2011) Prognostic association of YB-1 expression in breast cancers: a matter of antibody. PLoS One 6: e20603.
6. Lee C, Dhillon J, Wang MY, Gao Y, Hu K, et al. (2008) Targeting YB-1 in HER-2 overexpressing breast cancer cells induces apoptosis via the mTOR/STAT3 pathway and suppresses tumor growth in mice. Cancer Res 68: 8661-8666.
7. Basaki Y, Taguchi K, Izumi H, Murakami Y, Kubo T, et al. (2010) Y-box binding protein-1 (YB-1) promotes cell cycle progression through CDC6-dependent pathway in human cancer cells. Eur J Cancer 46: 954-965.
8. Rajewsky N (2006) microRNA target predictions in animals. Nat Genet 38 Suppl: S8-13.
9. Blenkiron C, Goldstein LD, Thorne NP, Spiteri I, Chin SF, et al. (2007) MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype. Genome Biol 8: R214.
10. Majumder S, Jacob ST (2011) Emerging role of microRNAs in drug-resistant breast cancer. Gene Expr 15: 141-151.
11. Ma L, Teruya-Feldstein J, Weinberg RA (2007) Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 449: 682-688. (Pubitemid 47552092)
12. Evdokimova V, Ruzanov P, Anglesio MS, Sorokin AV, Ovchinnikov LP, et al. (2006) Akt-mediated YB-1 phosphorylation activates translation of silent mRNA species. Mol Cell Biol 26: 277-292.
13. Evdokimova V, Tognon C, Ng T, Ruzanov P, Melnyk N, et al. (2009) Translational activation of snail1 and other developmentally regulated transcription factors by YB-1 promotes an epithelial-mesenchymal transition. Cancer Cell 15: 402-415.
14. Hsieh AC, Liu Y, Edlind MP, Ingolia NT, Janes MR, et al. (2012) The translational landscape of mTOR signalling steers cancer initiation and metastasis. Nature 485: 55-61.
15. Moss EG, Tang L (2003) Conservation of the heterochronic regulator Lin-28, its developmental expression and microRNA complementary sites. Dev Biol 258: 432-442. (Pubitemid 36683139)
16. Yang WH, Bloch DB (2007) Probing the mRNA processing body using protein macroarrays and "autoantigenomics". RNA 13: 704-712.
17. Liu J, Valencia-Sanchez MA, Hannon GJ, Parker R (2005) MicroRNA-dependent localization of targeted mRNAs to mammalian P-bodies. Nat Cell Biol 7: 719-723. (Pubitemid 40975754)
18. Kedersha N, Anderson P (2007) Mammalian stress granules and processing bodies. Methods Enzymol 431: 61-81.
19. Hock J, Weinmann L, Ender C, Rudel S, Kremmer E, et al. (2007) Proteomic and functional analysis of Argonaute-containing mRNA-protein complexes in human cells. EMBO Rep 8: 1052-1060. (Pubitemid 350042341)
20. Kato M, Wang L, Putta S, Wang M, Yuan H, et al. (2010) Post-transcriptional up-regulation of Tsc-22 by Ybx1, a target of miR-216a, mediates TGF-{beta}-induced collagen expression in kidney cells. J Biol Chem 285: 34004-34015.
21. Zhu X, Li Y, Shen H, Li H, Long L, et al. (2013) miR-137 restoration sensitizes multidrug-resistant MCF-7/ADM cells to anticancer agents by targeting YB-1. Acta Biochim Biophys Sin (Shanghai) 45: 80-86.
22. Lasham A, Samuel W, Cao H, Patel R, Mehta R, et al. (2012) YB-1, the E2F pathway, and regulation of tumor cell growth. J Natl Cancer Inst 104: 133-146.
23. Moore LM, Kivinen V, Liu Y, Annala M, Cogdell D, et al. (2013) Transcriptome and small RNA deep sequencing reveals deregulation of miRNA biogenesis in human glioma. J Pathol 229: 449-459.
24. Chambers AF (2009) MDA-MB-435 and M14 cell lines: identical but not M14 melanoma? Cancer Res 69: 5292-5293.
25. Hollestelle A, Schutte M (2009) Comment Re: MDA-MB-435 and M14 cell lines: identical but not M14 Melanoma? Cancer Res 69: 7893.
26. Smyth GK (2004) Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3: Article3.
27. Cohen SB, Ma W, Valova VA, Algie M, Harfoot R, et al. (2010) Genotoxic stress-induced nuclear localization of oncoprotein YB-1 in the absence of proteolytic processing. Oncogene 29: 403-410.
28. Svitkin YV, Evdokimova VM, Brasey A, Pestova TV, Fantus D, et al. (2009) General RNA-binding proteins have a function in poly(A)-binding protein-dependent translation. EMBO J 28: 58-68.
29. Skabkina OV, Lyabin DN, Skabkin MA, Ovchinnikov LP (2005) YB-1 autoregulates translation of its own mRNA at or prior to the step of 40S ribosomal subunit joining. Mol Cell Biol 25: 3317-3323. (Pubitemid 40464331)
30. Dong J, Akcakanat A, Stivers DN, Zhang J, Kim D, et al. (2009) RNA-binding specificity of Y-box protein 1. RNA Biol 6: 59-64.
31. Lopez de Silanes I, Zhan M, Lal A, Yang X, Gorospe M (2004) Identification of a target RNA motif for RNA-binding protein HuR. Proc Natl Acad Sci U S A 101: 2987-2992. (Pubitemid 38327723)
32. Huang Y, Genova G, Roberts M, Jackson FR (2007) The LARK RNA-binding protein selectively regulates the circadian eclosion rhythm by controlling E74 protein expression. PLoS One 2: e1107.
33. Rattenbacher B, Beisang D, Wiesner DL, Jeschke JC, von Hohenberg M, et al. (2010) Analysis of CUGBP1 targets identifies GU-repeat sequences that mediate rapid mRNA decay. Mol Cell Biol 30: 3970-3980.
34. Guil S, Long JC, Caceres JF (2006) hnRNP A1 relocalization to the stress granules reflects a role in the stress response. Mol Cell Biol 26: 5744-5758. (Pubitemid 44134331)
35. Buchan JR, Parker R (2009) Eukaryotic stress granules: the ins and outs of translation. Mol Cell 36: 932-941.
36. Belian E, Kurucz R, Treue D, Lage H (2010) Effect of YB-1 on the regulation of micro RNA expression in drug-sensitive and drug-resistant gastric carcinoma cells. Anticancer Res 30: 629-633.
37. Bockhorn J, Dalton R, Nwachukwu C, Huang S, Prat A, et al. (2013) MicroRNA-30c inhibits human breast tumour chemotherapy resistance by regulating TWF1 and IL-11. Nat Commun 4: 1393.
38. Sugimura K, Miyata H, Tanaka K, Hamano R, Takahashi T, et al. (2012) Let-7 expression is a significant determinant of response to chemotherapy through the regulation of IL-6/STAT3 pathway in esophageal squamous cell carcinoma. Clin Cancer Res 18: 5144-5153.
39. Schepeler T, Reinert JT, Ostenfeld MS, Christensen LL, Silahtaroglu AN, et al. (2008) Diagnostic and prognostic microRNAs in stage II colon cancer. Cancer Res 68: 6416-6424.
40. Volinia S, Galasso M, Costinean S, Tagliavini L, Gamberoni G, et al. (2010) Reprogramming of miRNA networks in cancer and leukemia. Genome Res 20: 589-599.
41. Hummel R, Hussey DJ, Haier J (2010) MicroRNAs: predictors and modifiers of chemo- and radiotherapy in different tumour types. Eur J Cancer 46: 298-311.
42. Bockhorn J, Yee K, Chang YF, Prat A, Huo D, et al. (2013) MicroRNA-30c targets cytoskeleton genes involved in breast cancer cell invasion. Breast Cancer Res Treat 137: 373-382.
43. Yun J, Frankenberger CA, Kuo WL, Boelens MC, Eves EM, et al. (2011) Signalling pathway for RKIP and Let-7 regulates and predicts metastatic breast cancer. EMBO J 30: 4500-4514.
44. Peter ME (2009) Let-7 and miR-200 microRNAs: guardians against pluripotency and cancer progression. Cell Cycle 8: 843-852.
45. Hsieh IS, Chang KC, Tsai YT, Ke JY, Lu PJ, et al. (2013) MicroRNA-320 suppresses the stem cell-like characteristics of prostate cancer cells by downregulating the Wnt/beta-catenin signaling pathway. Carcinogenesis 34: 530-538.
46. Yu F, Deng H, Yao H, Liu Q, Su F, et al. (2010) Mir-30 reduction maintains self-renewal and inhibits apoptosis in breast tumor-initiating cells. Oncogene 29: 4194-4204.
47. Yu F, Yao H, Zhu P, Zhang X, Pan Q, et al. (2007) let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell 131: 1109-1123. (Pubitemid 350235025)
48. To K, Fotovati A, Reipas KM, Law JH, Hu K, et al. (2010) Y-box binding protein-1 induces the expression of CD44 and CD49f leading to enhanced self-renewal, mammosphere growth, and drug resistance. Cancer Res 70: 2840-2851.
49. Viswanathan SR, Daley GQ (2010) Lin28: A microRNA regulator with a macro role. Cell 140: 445-449.
50. Zhou J, Ng SB, Chng WJ (2013) LIN28/LIN28B: an emerging oncogenic driver in cancer stem cells. Int J Biochem Cell Biol 45: 973-978.
51. Wilbert ML, Huelga SC, Kapeli K, Stark TJ, Liang TY, et al. (2012) LIN28 binds messenger RNAs at GGAGA motifs and regulates splicing factor abundance. Mol Cell 48: 195-206.
52. Wei WJ, Mu SR, Heiner M, Fu X, Cao LJ, et al. (2012) YB-1 binds to CAUC motifs and stimulates exon inclusion by enhancing the recruitment of U2AF to weak polypyrimidine tracts. Nucleic Acids Res 40: 8622-8636.
53. Lv K, Liu L, Wang L, Yu J, Liu X, et al. (2012) Lin28 mediates paclitaxel resistance by modulating p21, Rb and Let-7a miRNA in breast cancer cells. PLoS One 7: e40008.
54. Mantwill K, Kohler-Vargas N, Bernshausen A, Bieler A, Lage H, et al. (2006) Inhibition of the multidrug-resistant phenotype by targeting YB-1 with a conditionally oncolytic adenovirus: implications for combinatorial treatment regimen with chemotherapeutic agents. Cancer Res 66: 7195-7202. (Pubitemid 44197698)
55. Feng C, Neumeister V, Ma W, Xu J, Lu L, et al. (2012) Lin28 regulates HER2 and promotes malignancy through multiple mechanisms. Cell Cycle 11: 2486-2494.
56. Kalra J, Sutherland BW, Stratford AL, Dragowska W, Gelmon KA, et al. (2010) Suppression of Her2/neu expression through ILK inhibition is regulated by a pathway involving TWIST and YB-1. Oncogene 29: 6343-6356.
57. Hafner M, Max KE, Bandaru P, Morozov P, Gerstberger S, et al. (2013) Identification of mRNAs bound and regulated by human LIN28 proteins and molecular requirements for RNA recognition. RNA.
58. Kallen AN, Ma J, Huang Y (2012) Does Lin28 Antagonize miRNA-Mediated Repression by Displacing miRISC from Target mRNAs? Front Genet 3: 240.
59. Bhattacharyya SN, Habermacher R, Martine U, Closs EI, Filipowicz W (2006) Relief of microRNA-mediated translational repression in human cells subjected to stress. Cell 125: 1111-1124. (Pubitemid 43866197)
60. Bratkovic T, Rogelj B (2011) Biology and applications of small nucleolar RNAs. Cell Mol Life Sci 68: 3843-3851.
61. Lui L, Lowe T (2013) Small nucleolar RNAs and RNA-guided post-transcriptional modification. Essays Biochem 54: 53-77.
62. Gee HE, Buffa FM, Camps C, Ramachandran A, Leek R, et al. (2011) The small-nucleolar RNAs commonly used for microRNA normalisation correlate with tumour pathology and prognosis. Br J Cancer 104: 1168-1177.
63. Su H, Xu T, Ganapathy S, Shadfan M, Long M, et al. (2013) Elevated snoRNA biogenesis is essential in breast cancer. Oncogene.
64. Falaleeva M, Stamm S (2013) Processing of snoRNAs as a new source of regulatory non-coding RNAs: snoRNA fragments form a new class of functional RNAs. Bioessays 35: 46-54.
65. Martens-Uzunova ES, Olvedy M, Jenster G (2013) Beyond microRNA - Novel RNAs derived from small non-coding RNA and their implication in cancer. Cancer Lett.
66. Kishore S, Khanna A, Zhang Z, Hui J, Balwierz PJ, et al. (2010) The snoRNA MBII-52 (SNORD 115) is processed into smaller RNAs and regulates alternative splicing. Hum Mol Genet 19: 1153-1164.
67. Gonda K, Wudel J, Nelson D, Katoku-Kikyo N, Reed P, et al. (2006) Requirement of the protein B23 for nucleolar disassembly induced by the FRGY2a family proteins. J Biol Chem 281: 8153-8160. (Pubitemid 43847434)
68. Bargou RC, Jurchott K, Wagener C, Bergmann S, Metzner S, et al. (1997) Nuclear localization and increased levels of transcription factor YB-1 in primary human breast cancers are associated with intrinsic MDR1 gene expression. Nat Med 3: 447-450. (Pubitemid 27145688)
69. Di Costanzo A, Troiano A, di Martino O, Cacace A, Natale CF, et al. (2012) The p63 protein isoform DeltaNp63alpha modulates Y-box binding protein 1 in its subcellular distribution and regulation of cell survival and motility genes. J Biol Chem 287: 30170-30180.
70. Michel CI, Holley CL, Scruggs BS, Sidhu R, Brookheart RT, et al. (2011) Small nucleolar RNAs U32a, U33, and U35a are critical mediators of metabolic stress. Cell Metab 14: 33-44.
71. Ivanov P, Emara MM, Villen J, Gygi SP, Anderson P (2011) Angiogenin-induced tRNA fragments inhibit translation initiation. Mol Cell 43: 613-623.
72. Xia J, Zhang W (2012) Noncanonical microRNAs and endogenous siRNAs in lytic infection of murine gammaherpesvirus. PLoS One 7: e47863.
73. Zhou M, Sun J, Wang QH, Song LQ, Zhao G, et al. (2011) Genome-wide analysis of clustering patterns and flanking characteristics for plant microRNA genes. FEBS J 278: 929-940.
74. Nordentoft I, Birkenkamp-Demtroder K, Agerbaek M, Theodorescu D, Ostenfeld MS, et al. (2012) miRNAs associated with chemo-sensitivity in cell lines and in advanced bladder cancer. BMC Med Genomics 5: 40.
75. Lee K, Kunkeaw N, Jeon SH, Lee I, Johnson BH, et al. (2011) Precursor miR-886, a novel noncoding RNA repressed in cancer, associates with PKR and modulates its activity. RNA 17: 1076-1089.
76. Jeon SH, Lee K, Lee KS, Kunkeaw N, Johnson BH, et al. (2012) Characterization of the direct physical interaction of nc886, a cellular non-coding RNA, and PKR. FEBS Lett 586: 3477-3484.
77. Dabo S, Meurs EF (2012) dsRNA-dependent protein kinase PKR and its role in stress, signaling and HCV infection. Viruses 4: 2598-2635.
78. Guo L, Liang T, Gu W, Xu Y, Bai Y, et al. (2011) Cross-mapping events in miRNAs reveal potential miRNA-mimics and evolutionary implications. PLoS One 6: e20517.
79. Emara MM, Ivanov P, Hickman T, Dawra N, Tisdale S, et al. (2010) Angiogenin-induced tRNA-derived stress-induced RNAs promote stress-induced stress granule assembly. J Biol Chem 285: 10959-10968.
80. Reid G, Wallant NC, Patel R, Antonic A, Saxon-Aliifaalogo F, et al. (2009) Potent subunit-specific effects on cell growth and drug sensitivity from optimised siRNA-mediated silencing of ribonucleotide reductase. J RNAi Gene Silencing 5: 321-330.
81. Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, et al. (2003) Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res 31: e15.
82. Hanina SA, Mifsud W, Down TA, Hayashi K, O'Carroll D, et al. (2010) Genome-wide identification of targets and function of individual MicroRNAs in mouse embryonic stem cells. PLoS Genet 6: e1001163.
83. Lasham A, Herbert M, Coppieters 't Wallant N, Patel R, Feng S, et al. (2010) A rapid and sensitive method to detect siRNA-mediated mRNA cleavage in vivo using 5 9 RACE and a molecular beacon probe. Nucleic Acids Res 38: e19.
84. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408. (Pubitemid 34164012)
85. Meiri E, Levy A, Benjamin H, Ben-David M, Cohen L, et al. (2010) Discovery of microRNAs and other small RNAs in solid tumors. Nucleic Acids Res 38: 6234-6246.
86. Ono M, Scott MS, Yamada K, Avolio F, Barton GJ, et al. (2011) Identification of human miRNA precursors that resemble box C/D snoRNAs. Nucleic Acids Res 39: 3879-3891.
87. Langenberger D, Bermudez-Santana CI, Stadler PF, Hoffmann S (2010) Identification and classification of small RNAs in transcriptome sequence data. Pac Symp Biocomput: 80-87.